Login
$COLL
$23.00 -$0.21 (0.9%) Close

Company Executives

$COLL Management Team

Mr. Dean Patras

Chief People Officer

Age -
Compensation -
Sex Male

Mr. David Dieter

Executive Vice President

General Counsel

Corporate Secretary

Age 61
Compensation -
Sex Male

Ms. Jane Gonnerman

Executive Vice President - Strategy and Corporate Development

Age -
Compensation -
Sex Female

Mr. Vikram Karnani

President

Chief Executive Officer

Director

Age 50
Compensation $10.78M USD
Sex Male

Ms. Colleen Tupper

Chief Financial Officer

Executive Vice President

Age 49
Compensation $3.190M USD
Sex Female

Mr. Scott Dreyer

Executive Vice President

Chief Commercial Officer

Age 53
Compensation $2.791M USD
Sex Male

Mr. Gino Santini

Independent Chairman of the Board

Age 68
Compensation $362.0K USD
Sex Male

Dr. Thomas Smith

Executive Vice President

Chief Medical Officer

Age 64
Compensation $2.500M USD
Sex Male
Directors
8
serving now
Independent
0 of 1
stated in the proxy; 7 not stated
Average tenure
7.2 years
from year joined
CEO also chairs the board
No
Gino Santini
Director Age On board Independent Committees Other public boards 2025 pay Source
Vikram Karnani
51 2024
2 years
Not independent None stated Dyne Therapeutics, Inc. Paid as CEO
Rita Balice-Gordon
65 2020
6 years
Not stated
Nominating and Corporate Governance Transaction
H. Lundbeck A/S Not stated
Garen Bohlin
78 2015
11 years
Not stated
Audit · Chair Compliance
Karyopharm Therapeutics, Inc. $366,639
John Freund
72 2014
12 years
Not stated
Compensation · Chair Audit
SI-Bone, Inc. $367,268
John Fallon Leaving at the meeting
Not stated 2015
11 years
Not stated None stated None stated $366,268
Nancy Lurker
68 2025
1 year
Not stated
Compliance · Chair Compensation
EyePoint Pharmaceuticals, Inc., Alkermes plc $743,776
Carlos Paya
67 2025
1 year
Not stated
Transaction · Chair Nominating and Corporate Governance
Vaxcyte, Inc. Not stated
Gino Santini
69 2012
14 years
Not stated
Compensation Transaction
Compass Pathways PLC $400,963
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 7, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support